Cimpress N.V. (CMPR) Tops Q2 EPS by 10c

Cimpress N.V. (NASDAQ: CMPR) reported Q2 EPS of $0.93, $0.10 better than the analyst estimate of $0.83. Revenue for the quarter came in at $762 million versus the consensus estimate of $692.37 million.

For earnings history and earnings-related data on Cimpress N.V. (CMPR) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c